癌症查的民主化,还是浪费宝贵资源?
Miyo K Chatanaka1, Eleftherios P Diamandis2
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Clinical chemistry and laboratory medicine
|December 12, 2025
概括
使用循环瘤DNA (ctDNA) 的液体活检显示了早期癌症查的前景. 然而,在临床广泛采用之前,准确检测小瘤和管理假阳性仍然存在挑战.
科学领域:
- 在瘤学瘤学.
- 分子诊断学 分子诊断
- 生物技术是生物技术.
背景情况:
- 循环瘤DNA (ctDNA) 分析是一种用于癌症诊断的新方法.
- 液体活检是一种使用ctDNA的最小侵入性技术,具有早期癌症检测的潜力.
- 对于ctDNA用于查的临床实用性正在积极研究和开发中.
研究的目的:
- 为癌症查中ctDNA的应用提供最新信息.
- 突出临床实施前需要进一步研究和验证的关键问题.
- 强调需要对液体活检技术进行强有力的验证.
主要方法:
- 对基于ctDNA的癌症查进行当前研究和临床数据的审查和分析.
- 讨论技术挑战,包括对小瘤的敏感性和特异性.
- 评估对患者结果和医疗保健资源的潜在影响.
主要成果:
- 基于ctDNA的液体活检可以检测多种癌症,可能在早期阶段.
- 对于小,局部瘤的敏感性 (潜在的假阴性) 存在重大担忧.
- ctDNA测试的错误阳性率是一个值得关注的问题,特别是在低患病率的癌症中.
结论:
- 在广泛临床使用之前,对ctDNA液体活检技术的彻底验证至关重要.
- 确保ctDNA测试带来可行的干预措施,改善患者的生存率和生活质量至关重要.
- 解决敏感性和特异性的挑战对于将液体活检负责任地整合到癌症治疗中至关重要.
相关概念视频
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629


